Clinical Trials Browser

Phase 2 × OTHER × Urothelial Bladder Carcinoma × Clear all

NCT06133517 2026-03-16

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Phase 2 Active not recruiting

Urothelial Bladder Carcinoma

NCT02736266 2023-07-18

PURE-01

Phase 2 Completed

Urothelial Bladder Carcinoma